$TWN

The Taiwan Fund, Inc. Announces 3rd Quarter Earnings

The Taiwan Fund, Inc. (NYSE: TWN) reported net asset value per share of $116.90 as of May 31, 2026, up from $79.33 on Feb 28, 2026. Its NYSE share price was $99.15 on May 29, 2026, a 15.18% discount to NAV. Three-month total return was 47.36% vs TAIEX 26.12%.

Original reporting
Published Jul 15, 2026, 8:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 15, 2026, 8:59 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$TWN
Bullish
medium confidence
Mentioned
$TWN
Relevance
6/10
alphai data visualization · based on prnewswire.com
Decision brief

The 30-second read

$TWNBullishMed
01

Why it matters

The quarter’s NAV increase and the reported discount level provide fresh inputs for traders focused on CEF relative value and Taiwan equity exposure, but the release lacks new portfolio or distribution specifics that would drive a large repricing.

02

Market read

TWN’s updated NAV and discount figures can affect near-term positioning for discount traders and investors comparing Taiwan equity exposure versus the benchmark.

03

What to watch

The article does not detail portfolio changes, distribution amount, leverage, or expense changes, which are often key for sustaining discount convergence.

Relevance 6/10Novelty 6/10Timing: after-hours, following the fund’s 3Q performance update for the period ended May 31, 2026

Background

The Taiwan Fund, Inc. is a non-diversified closed-end investment company investing primarily in equity securities listed on the Taiwan Stock Exchange; it reports NAV and share-price discount/premium.

Company-level read

Ticker impact

$TWNBullishMedium confidence
Context

The Taiwan Fund reports NAV of $116.90 at May 31, 2026 and a 15.18% discount to share price on May 29, 2026.

Expected impact

Likely modest support for the stock if the market views the widening/narrowing discount and strong NAV total return as favorable, but magnitude is typically limited for CEFs.

Evidence & confidence

The article provides fresh, specific NAV and discount figures for the quarter, which can influence CEF flows and relative-value positioning, though it does not include new holdings, guidance, or distributions beyond what is implied.

Market effects

Adds a data point on Taiwan equity exposure performance via a CEF wrapper, potentially informing relative-value sentiment toward Taiwan-focused closed-end funds.

Performance is benchmarked to TAIEX, reinforcing how Taiwan equities translated into USD returns over the quarter.

Limited spillover beyond investors tracking Taiwan equity risk and CEF discount dynamics.

Counterpoint

A strong NAV total return does not guarantee the share price will close the discount, especially if market discount drivers (rates, liquidity, risk appetite) dominate.

Key entities

  • The Taiwan Fund, Inc.

    Reports 3Q ended May 31, 2026 NAV, share price, discount to NAV, and realized/unrealized gains.

  • TAIEX Total Return Index

    Used as a performance comparator for the same period in US$ terms.

Related articles

$TWNMed

Food safety top priority, president says

President William Lai said food safety is the top priority amid a contaminated cooking oil incident. Taiwan’s FDA said Central Union Oil notified it that soy-based oil contained excessive benzopyrene; 1,300 tonnes were distributed to Taisun, Fwusow and Formosa. FDA ordered recalls/withdrawals, expanding to 360 companies, 18 products and 30 batches; listed retailers include Regent Taipei, Carrefour, Lian Hwa, Louisa Coffee and others.

$WATMedAI 8/10

Waters Q2 Earnings Call Highlights

Waters (NYSE:WAT) reported Q2 updates from its earnings call. Materials Science Division revenue rose to $87M. Biosciences and Diagnostic Solutions acquired from BD generated $817M revenue. Waters raised FY organic constant-currency growth outlook to 7% to 9%, projecting FY reported revenue of $3.370B to $3.431B and adjusted EPS of $14.45 to $14.65.

$VTEXMedAI 8/10

VTEX Q2 Earnings Call Highlights

VTEX (NYSE:VTEX) reported Q2 margin and cash flow improvement and guided for Q3 and full-year low-single-digit FX-neutral subscription revenue growth and low-20% non-GAAP operating and free cash flow margins. Q2 non-GAAP subscription gross margin rose to 81.8%. Free cash flow rose 79% to $12.7M. VTEX repurchased 6.2M shares at $3.76.

$WMedAI 8/10

Wayfair Q2 Earnings Call Highlights

Wayfair (NYSE:W) said Q2 new-order growth accelerated for a fourth straight quarter to a post-COVID high, citing U.S. gains from pricing, selection, delivery speed and availability, plus initiatives like Wayfair Rewards and stores. Q3 revenue growth is forecast at high-single digits. Perigold sales grew over 35% YoY and exceeded $400M annual. Q2 gross margin was 30.0%, adjusted EBITDA $242M, and free cash flow $301M. The company issued $400M notes to redeem 2028 converts.

$VYXMed

NCR Voyix Q2 Earnings Call Highlights

NCR Voyix (NYSE:VYX) reported Q2 progress on enterprise platform transformations, including a remote Voyix POS installation for a large European grocery retailer completed in about half the usual time. Retail signed 40+ customers; retail revenue fell 20% to $365M due to hardware transition, but adjusted EBITDA rose 20% to $97M. Restaurant revenue fell 23% to $158M. Non-GAAP EPS was $0.17. Full-year 2026 outlook maintained: revenue $2.188B-$2.303B, adj EBITDA $432M-$447M, EPS $0.89-$0.92.

$VOYAMed

Voya Financial Q2 Earnings Call Highlights

Voya Financial (NYSE:VOYA) reported Q2 adjusted operating earnings of $190M for Retirement, with defined-contribution net inflows of $8.1B. Retirement fee revenue rose 10% and margins were 38%. Investment Management adjusted operating earnings rose 12% to $57M. Employee Benefits adjusted operating earnings were $22M in Q2. Voya repurchased $150M of stock in Q2.